✦ LIBER ✦

Difference in hTERT gene expressions between HbsAg-positive and HbsAg-negative hepatocellular Carcinoma

✍ Scribed by Guo Yueqing; Zhou Xu; Liu Enyu; Li Xingrui; Liu Jinwen; Yang Zhifang; Yi Jilin

Publisher: Springer-Verlag
Year: 2005
Tongue: Chinese
Weight: 671 KB
Volume: 25
Category: Article
ISSN: 0510-9752
DOI: 10.1007/bf02828150

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B Virus Replication in Souther

Hepatitis B Virus Replication in Southern African Blacks with HBsAg-Positive Hepatocellular Carcinoma

✍ Ernest Song; Geoffrey M. Dusheiko; Sheila Bowyer; Michael C. Kew 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 389 KB 👁 1 views

Sera from 106 southern African blacks with hepatocellular carcinoma and hepatitis B surface antigenemia (HBsAg) were tested for hepatitis B viral DNA (HBV-DNA) activity, HBV-DNA polymerase concentrations, and HBV e antigen (HBeAg) and antibody (anti-HBe) to investigate the state of viral replication

Biologic significance of the detection o

Biologic significance of the detection of HBsAg and HBcAg in liver and tumor from 204 HBsAg-positive patients with primary hepatocellular carcinoma

✍ Dr. Hey-Chi Hsu; Tsung-Teh Wu; Jin-Chuan Sheu; Chieng-Yen Wu; Tzyy-Jen Chiou; Ch 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 557 KB

Clinical, serologic, and immunologic eff

Clinical, serologic, and immunologic effects of human leukocyte interferon in HBsAg-positive primary hepatocellular carcinoma

✍ Prem V. Nair; Myron J. Tong; Raymond Kempf; Ruth Co; Shou-Dong Lee; Cheryl L. Ve 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 1 views

Five patients with hepatitis B surface antigen (HBsAg) positive chronic hepatitis and histologically confirmed primary hepatocellular carcinoma (PHC) were treated with 3 X lo6 units/day of partially purified human leukocyte interferon intramuscularly for 2 consecutive months. During interferon thera

Demonstration of HCV-RNA and HBV-DNA in

Demonstration of HCV-RNA and HBV-DNA in the serum of HBsAg negative patients with hepatocellular carcinoma

✍ J. Enríquez; K. Fuchs; F. J. Martínez Cerezo; R. Seminago; P. Madoz; J. Torras; 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 650 KB

Difference in gene expression for matrix

Difference in gene expression for matrix metalloproteinase-1 between early and advanced hepatocellular carcinomas

✍ I Okazaki; N Wada; M Nakano; A Saito; K Takasaki; M Doi; K Kameyama; Y Otani; K 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

The process of stromal invasion by cancer cells suggests a The histological observation that well-differentiated role of interstitial collagenase (MMP-1) in early HCC, becancer cells in early hepatocellular carcinoma (HCC) incause other MMPs cannot degrade interstitial stroma. The vade portal tracts

Is anti-hbc IgM a useful clinical test i

Is anti-hbc IgM a useful clinical test in patients with HBsAg-positive chronic hepatitis or primary hepatocellular carcinoma?

✍ Min Chan Lai; Myron J. Tong; Marek J. Nowicki; Shou-Dong Lee 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 508 KB

Seventy HBsAg-positive patients, including 24 with primary hepatocellular carcinoma, 34 with chronic active hepatitis, 12 with chronic persistent hepatitis and 30 asymptomatic healthy hepatitis B virus carriers were tested for anti-HBc IgM using the Corzyme-M test. Anti-HBc IgM was detected in 50% o